LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).

Assistance Publique - Hôpitaux de Paris, CHU Necker-Enfants Malades, Service de Virologie, Paris, France.
Journal of Medical Virology (Impact Factor: 2.22). 02/2009; 81(2):217-23. DOI: 10.1002/jmv.21390
Source: PubMed

ABSTRACT HIV-1 diagnosis in babies born to seropositive mothers is one of the challenges of HIV epidemics in children. A simple, rapid protocol was developed for quantifying HIV-1 DNA in whole blood samples and was used in the ANRS French pediatric cohort in conditions of prevention of mother-to-child transmission. A quantitative HIV-1 DNA protocol (LTR real-time PCR) requiring small blood volumes was developed. First, analytical reproducibility was evaluated on 172 samples. Results obtained on blood cell pellets and Ficoll-Hypaque separated mononuclear cells were compared in 48 adult HIV-1 samples. Second, the protocol was applied to HIV-1 diagnosis in infants in parallel with plasma HIV-RNA quantitation. This prospective study was performed in children born between May 2005 and April 2007 included in the ANRS cohort. The assay showed good reproducibility. The 95% detection cut-off value was 6 copies/PCR, that is, 40 copies/10(6) leukocytes. HIV-DNA levels in whole blood were highly correlated with those obtained after Ficoll-Hypaque separation (r = 0.900, P < 0.0001). A total of 3,002 specimens from 1,135 infants were tested. The specificity of HIV-DNA and HIV-RNA assays was 100%. HIV-1 infection was diagnosed in nine infants before age 60 days. HIV-DNA levels were low, underlining the need for sensitive assays when highly active antiretroviral therapy (HAART) has been given. The performances of this HIV-DNA assay showed that it is adapted to early diagnosis in children. The results were equivalent to those of HIV-RNA assay. HIV-DNA may be used even in masked primary infection in newborns whose mothers have received HAART.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Ultra-sensitive laboratory assays based on the Polymerase Chain Reaction (PCR) are playing an increasingly important role in HIV cure-related research. This article reviews the different assays available and how they have evolved. There is a great need for their standardization and for the establishment of reference reagents and testing algorithms to evaluate potential HIV cure-related treatments.
    Journal of AIDS & Clinical Research 05/2014; Suppl 6. DOI:10.4172/2155-6113.S6-002 · 6.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasma viral load and CD4 counts are effective for clinical monitoring, but they do not give a full representation of HIV-1 quasispecies in cellular reservoirs, the major repository of replication-competent HIV-1 in infected individuals. We sought to develop a diagnostic system that could stimulate the replication- competent HIV-1 reservoirs for enhanced clinical monitoring including selection of antiretroviral regimens. Whole blood from 45 HIV-infected individuals was collected into 1 ViraStim™ HIV-1 activation tube and 1 EDTA tube. Samples were tested for viral load and cell-type specific HIV-1 replication. Further, 7 matched activated/non-activated samples were sequenced using the TRUGENE® HIV-1 Genotyping Kit. The percentage of patients with replication-competent virus in PBMCs varied depending on the baseline plasma viral load in the EDTA tubes. Six out of 24 patients with starting plasma viral load<20 copies/mL (cp/mL), 6 out of 8 patients with starting viral loads >20 and <1000 cp/mL, and 8 patients out of 13 with starting viral loads >1000 all showed an increase in viral replication greater than 5-fold. This increase came from cellular reservoirs in blood as determined by Simultaneous Ultrasensitive Subpopulation Staining/Hybridization In Situ (SUSHI). When comparing resistance genotypes in plasma from activation tubes compared to EDTA tubes for 7 patients, all patients showed additional mutations in the activation tube, while 3 patients demonstrated additional genotypic resistance determinants compared to EDTA tubes. We show that HIV-1 viral replication can be stimulated directly from infected whole blood. The sequencing results showed 3 of 7 cases demonstrated additional drug resistance following stimulation.
    Journal of Clinical Microbiology 10/2014; 53(1). DOI:10.1128/JCM.02539-14 · 4.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The quantitative measurement of various HIV-1 DNA forms including total, unintegrated and integrated provirus play an increasingly important role in HIV-1 infection monitoring and treatment-related research. We report the development and validation of a SYBR Green real time PCR (TotUFsys platform) for the simultaneous quantification of total and extrachromosomal HIV-1 DNA forms in patients. This innovative technique makes it possible to obtain both measurements in a single PCR run starting from frozen blood employing the same primers and standard curve. Moreover, due to identical amplification efficiency, it allows indirect estimation of integrated level. To specifically detect 2-LTR a qPCR method was also developed.
    PLoS ONE 11/2014; 9(11):e111919. DOI:10.1371/journal.pone.0111919 · 3.53 Impact Factor